Michael Barbella, Managing Editor05.09.24
CurvaFix Inc. has appointed J. Kurt Jacobus, Ph.D., to its Board of Directors.
Dr. Jacobus brings nearly two decades of leadership and expertise in the medtech industry to his board position. He is currently chairman/CEO of restor3d Inc., a provider of personalized orthopedic implants.
“We are delighted to welcome Kurt to CurvaFix’s Board of Directors,” CurvaFix CEO Mark Foster said. “His extensive experience and track record of success in the orthopedic medical device sector makes him an invaluable addition to our board. We look forward to leveraging his insights and guidance as we continue to innovate and advance minimally invasive pelvic fracture repair for both high-energy trauma and fragility fracture patients.”
Before taking charge at restor3d, Dr. Jacobus was CEO of MedShape Inc., an orthopedic medical device company delivering devices with sustained compression in foot and ankle surgeries. At MedShape, he led the company’s growth and eventual acquisition by Enovis in 2021. He also co-founded Vertera Spine Inc., a pioneering medical device company that was acquired by NuVasive Inc. in 2017.
“I am honored to join CurvaFix’s Board of Directors,” Dr. Jacobus stated. “CurvaFix’s commitment to changing the course of care for elderly patients suffering with fragility fractures of the pelvis and pelvic fractures resulting from trauma is critical and important work, especially in such an overcrowded orthopedic industry. This technology demonstrates the potential for significant pain relief and faster mobility. I am excited to contribute to the company’s continued success.”
Dr. Jacobus earned a Ph.D. in mechanical engineering from the University of Illinois at Urbana-Champaign, where his research focused on materials science and manufacturing processes. He also earned master’s and bachelor’s degrees in mechanical engineering from the Georgia Institute of Technology.
CurvaFix Inc. is a privately held medical device company headquartered in Bellevue, Wash., that develops implantable products to improve fracture repair in curved bones. The company is focusing on pelvic fragility fractures and high-energy pelvic fractures. The CurvaFix IM Implant has received 510(k) clearance from the U.S. Food and Drug Administration (FDA).
Dr. Jacobus brings nearly two decades of leadership and expertise in the medtech industry to his board position. He is currently chairman/CEO of restor3d Inc., a provider of personalized orthopedic implants.
“We are delighted to welcome Kurt to CurvaFix’s Board of Directors,” CurvaFix CEO Mark Foster said. “His extensive experience and track record of success in the orthopedic medical device sector makes him an invaluable addition to our board. We look forward to leveraging his insights and guidance as we continue to innovate and advance minimally invasive pelvic fracture repair for both high-energy trauma and fragility fracture patients.”
Before taking charge at restor3d, Dr. Jacobus was CEO of MedShape Inc., an orthopedic medical device company delivering devices with sustained compression in foot and ankle surgeries. At MedShape, he led the company’s growth and eventual acquisition by Enovis in 2021. He also co-founded Vertera Spine Inc., a pioneering medical device company that was acquired by NuVasive Inc. in 2017.
“I am honored to join CurvaFix’s Board of Directors,” Dr. Jacobus stated. “CurvaFix’s commitment to changing the course of care for elderly patients suffering with fragility fractures of the pelvis and pelvic fractures resulting from trauma is critical and important work, especially in such an overcrowded orthopedic industry. This technology demonstrates the potential for significant pain relief and faster mobility. I am excited to contribute to the company’s continued success.”
Dr. Jacobus earned a Ph.D. in mechanical engineering from the University of Illinois at Urbana-Champaign, where his research focused on materials science and manufacturing processes. He also earned master’s and bachelor’s degrees in mechanical engineering from the Georgia Institute of Technology.
CurvaFix Inc. is a privately held medical device company headquartered in Bellevue, Wash., that develops implantable products to improve fracture repair in curved bones. The company is focusing on pelvic fragility fractures and high-energy pelvic fractures. The CurvaFix IM Implant has received 510(k) clearance from the U.S. Food and Drug Administration (FDA).